Long‐COVID symptoms improved after MDMA and psilocybin therapy: A case report-Reference-Cited by-同舟云学术

Long‐COVID symptoms improved after MDMA and psilocybin therapy: A case report

Published:2024-05-28 Issue:6 Volume:12 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Chopra Harman¹,Furnish Tim²,Verduzco‐Gutierrez Monica³,Jevotovsky David S.⁴^ORCID,Castellanos Joel²

Affiliation:

1. Johns Hopkins School of Medicine Baltimore Maryland USA

2. University of California San Diego Health San Diego California USA

3. University of Texas San Antonio Health San Antonio Texas USA

4. New York University Grossman School of Medicine New York New York USA

Abstract

Key Clinical MessageLong‐COVID syndrome lacks effective holistic treatment options. We present a case of a 41‐year‐old fully vaccinated female with Long‐COVID syndrome who obtained significant symptomatic relief after self‐medicating with psilocybin and MDMA.AbstractLong‐COVID, a syndrome persisting after the acute phase of coronavirus disease 2019 (COVID‐19), lacks effective holistic treatment options. We present a case of a 41‐year‐old fully vaccinated female with Long‐COVID syndrome who obtained significant symptomatic relief by self‐prescribing psilocybin and MDMA. Future research is needed to assess safety and efficacy.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.8791

Reference17 articles.

1. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms

2. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments

3. Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems

4. The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry

5. Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS‐CoV ‐2 infection ( PASC ) patients

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-09